 |
|
|
| |
[poor] Quality of Hepatitis C care at an urban tertiary medical center
|
| |
| |
Reported by Jules Levin
IDSA San Diego Oct 17-21 2012
Sabrina A. Assoumou MD1, Wei Huang MA2, Benjamin P. Linas, MD MPH1,2
1 Section of infectious diseases, Department of Medicine, Boston University
School of Medicine, Boston, MA, USA
2 Boston University School of Public Health, Boston, MA, USA
This work is supported in part by the National Institutes of Health (5 T32 AI52074-05, K01 A1073193, R01 DA031059 )
CONCLUSIONS
- Study conducted at Boston Medical Center
- Outcomes: Centers for Medicare & Medicaid (CMS)- defined HCV quality indicators introduced in 2008:
HCV RNA testing
Genotype testing
Hep A & Hep B vaccinations
5,495 patients diagnosed with reactive HCV antibody
3,108 engaged in care
62% men
48% white
29% black
17% Latino
66% public insurance
27% private insurance
53% history of substance abuse
28% history of psych illness
13% history of HIV-infection
79% US born
no. of visits after diagnosis 10 median
58% HCV RNA testing
55% detectable HCV viremia
49% genotyping from 2008-2011 up from 18% in 2005-2007
15% Hep A vaccine
46% Hep B vaccine
patients seen by subspecialists more likely to have quality indicators completed
|
| |
|
|
|
|
|
